Controversies in Vaccine Advisory Decisions

This chapter explores the recent upheaval within the CDC's Advisory Committee on Immunization Practices, including the dismissal of all previous members and the appointment of new ones amidst controversy. The discussion underscores the implications of these changes for public health, vaccine regulations, and the response from the pharmaceutical industry. Participants also evaluate the qualifications of the new appointees and the significance of transparency in the vaccine approval process.